Akebia Therapeutics, Inc. ( AKBA) - Key Metrics
AKBA Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $0.22 | -$0.05 | $0.12 | $0.12 |
| 2025Q3 | $0.22 | $0 | $0.11 | $0.11 |
| 2025Q2 | $0.24 | $0 | $0.09 | $0.08 |
| 2025Q1 | $0.24 | $0.03 | -$0.06 | -$0.06 |
AKBA Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | -8.72 |
| 2025Q3 | ? | 334.66 |
| 2025Q2 | ? | 967.35 |
| 2025Q1 | ? | 18.49 |
AKBA
Price: $1.30
52 week price:
Earnings Per Share: -0.08 USD
Exchange: NCM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: United States
Volume: 1.3 million
Ebitda: -24.0 millionMarket Capitalization: 332.6 million